FDA Proposes Expanding Black Box Warning on Antidepressants
Posted on: Thursday, 3 May 2007, 15:00 CDT
The FDA has revealed that it is considering updating the existing black box warning on antidepressant labels to include warnings about increased risks of suicidal thinking and behavior in young adults ages 18 to 24 during the first few months of treatment.
The proposed labeling changes also state that studies did not show this increased risk in adults older than 24, and that adults ages 65 and older taking antidepressants have a decreased risk of suicidality. The proposed warning statements emphasize that depression and certain other serious psychiatric disorders are themselves the most important causes of suicide, the US regulator said.
The update follows the 2005 black box warning that was added to several antidepressants, describing a risk of suicidal behavior in children and teens. The negative publicity surrounding the decision prompted a drop in antidepressant sales in the US and across Europe.
The FDA emphasized that people currently prescribed antidepressant medications should not stop taking them. Those who have concerns should notify their health care providers.
Source: Datamonitor
Related Articles
- Elderly Antidepressant Risk May Be Less
- New Orleans Mayor Warns of Risk in Rebuilding Plan
- Iraq govt warns of risk of endless civil war
- Iraq government warns of risk of "endless civil war"
- Antidepressants' Risk of Suicide Now Called Low
- Pfizer to Label Celebrex Packaging With Warnings Against Risks of Cardiovascular Problems
- Pfizer Halts Arthritis Drug After Warning on Risks
- Corticosteroid Use After Hospital Discharge Among High-Risk Adults With Asthma
- Americans Over 40 Warned Over Risks of Vision Loss
- Parents: Kids Face Antidepressants Risk
 |
 |
User Comments (0)
RSS Feeds